Form D · Biotechnology

Innovative Cardiovascular Solutions, LLC

Kalamazoo, MI · CIK 0001579422

Offering snapshot reported Jan 3, 2022 · SEC filing

Reported sold
$655K
Offering amount: $5.3M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 15, 2021
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 3, 2022Initial$654,553No comparison10SEC filing
Oct 9, 2020Initial$269,553No comparison8SEC filing
Sep 5, 2018Initial$519,332No comparison16SEC filing
Apr 5, 2017Amendment$3,087,310$1,679,583vs May 18, 201697SEC filing
May 18, 2016Amendment$1,407,727$582,727vs Jul 27, 201523SEC filing
Jul 27, 2015Initial$825,000No comparison5SEC filing
Sep 8, 2014Amendment$3,058,600$1,520,000vs Mar 19, 201456SEC filing
Mar 19, 2014Initial$1,538,600No comparison25SEC filing
Jun 18, 2013Initial$335,000No comparison7SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0 (estimated)
Finders' fees
$0 (estimated)
Form D file number
021-427582

Source: Form D, filed Jan 3, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
William Merhi Director, Executive
Robert Plemmons Director, Executive
Shayne Plemmons Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1111 Short Road
Kalamazoo, MI, 49008